Search

everythinglearnresearchcommunity

for

Search:↓

Autophagy helps keep skin healthy and may improve treatments for skin diseases.

Biofield Energy Healing significantly increased hair growth by making hair root cells grow more.

Biofield Energy Healing may increase hair growth by enhancing cell proliferation.

PRP and cell therapies may help with hair loss, but more research is needed.

Improper diet, lifestyle, and stress are major causes of hair fall.

A 10-year-old girl with Fox Fordyce disease improved with treatment, suggesting the disease can occur before puberty and might be underdiagnosed in young girls.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

A substance from a specific gel helped to grow hair effectively in mice, suggesting it could potentially be used to treat hair loss in humans.

Fox Fordyce disease might be more common in prepubertal girls than thought and can be managed with treatment.

Fox Fordyce disease can occur in prepubertal girls and may be underdiagnosed.

Women who lost hair from childhood head radiation are more likely to face mental health issues than men.

The document concludes that identifying the cause of eyebrow and eyelash loss is key to treating it and improving quality of life.

Dendrobium officinale polysaccharides may help with hair growth, skin moisturization, and protection against oxidative damage.

The document concludes that proper recognition and treatment of skin appendage disorders are important for management.

Dupilumab can improve both atopic dermatitis and alopecia universalis.

Oral tofacitinib successfully treated total body hair loss in one patient.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

The combination of oral PUVA and corticosteroids helps regrow hair in severe alopecia areata.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

Diphenylcyclopropenone (DPCP) is effective in treating alopecia areata, with most patients showing significant hair regrowth.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

Alopecia areata causes varying hair loss patterns, affecting hair, nails, and possibly glands, with treatment outcomes depending on disease duration and extent.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Hispanic/Latinx patients with alopecia areata often have it before age 40, with females and certain health conditions like rheumatoid arthritis more commonly affected.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

Diphenylcyclopropenone is effective for treating alopecia areata but has a high relapse rate.

Alopecia areata is an autoimmune condition causing patchy hair loss, with treatments focusing on immune system regulation and hair regrowth.

Children with autoimmune hair loss have similar vitamin D levels to healthy kids, suggesting no extra screening is needed.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.